Heme-oxygenase-1 (HO-1), the rate limiting enzyme of heme degradation, has powerful antioxidant properties, related to production of the reactive oxygen species (ROS) scavenger bilirubin. However, some data suggest that HO-1 could also inhibit cellular production of ROS. Therefore, we investigated whether antioxidant properties of HO-1 could be mediated by modulation of the activity and/or expression of the heme-containing NAD(P)H oxidase, These results show that decrease in heme content due to HO-1 activation limits heme availability for maturation of the gp91 phox subunit and assembly of the functional NAD(P)H oxidase. This study provides a new mechanism to explain HO-1 antioxidant properties.
Introduction
In phagocytes, the NAD(P)H oxidase is the major source of superoxide anion, which represents, with hydrogen peroxide, a critical part of their armory of bactericidal mechanisms (1) . The whole oxidase is made of assembly of gp91 phox and p22 phox (which heterodimerize to form the cytochrome b 558 ) and p67 phox , p47 phox and Rac1 or 2 subunits. Gp91 phox , the catalytic moiety of the oxidase, is a plasma membrane-associated flavohemoprotein containing one flavin-adenine dinucleotide and two hemes that catalyses the NADPH-dependant reduction of oxygen to form superoxide (2) . Non phagocytic cells, such as vascular (3) and bronchial (4) smooth muscle, endothelial cells (5), fibroblasts (6) , thyroid cells (7), and prostate epithelial cells (8) also express gp91 phox or recently described homologs termed NOX (9) . In these cells, superoxide anion drives expression of numerous oxidant sensitive genes, and is therefore involved in redox signaling as a second intracellular messenger that controls important functions such as cell proliferation, apoptosis, inflammation, cell recruitment, and matrix turnover. Thus it appears that understanding mechanisms of regulation of superoxide production by the oxidase could have important physiological, pathophysiological and, probably, clinical implications in different conditions and disease states.
Heme oxygenase-1 1 Reagent following manufactor's instructions. Briefly, cells were seeded in 6-well plates at a density of 100 000 cells /well 24 hours before transfection. The proportions used were 4 µg DNA/ 20 µl transfection reagent/ well. Cells were incubated for 3 hours, then the medium was replaced with fresh medium containing 10% serum. Cytochrome c reduction assay and western blot for HO-1 expression was performed 48 hours after transfection. antibodies were used at 1/400 dilution for 30 minutes at room temperature. Cells were observed with a ZEISS LSM510 META confocal microscope using a X63/1.4 objective.
HO

RT-PCR amplification
Total RNA of RAW 264.7 cells were prepared with Trizol reagent. Polymerase chain reaction was performed using the high fidelity Taq Platinium PCR Supermix (Invitrogen, Cergy
Pontoise, France) and the following couples of primers : gp91 phox 5'-GCA CAC CGC CAT CCA CAC AA-3' and 5'-CCC CTC CGT CCA GTC TCC AA-3', p22 phox 5'-TTC CTG TTG TCG GTG CCT GC-3' and 5'-TTC TTT CGG ACC TCT GCG GG-3', p47 phox 5'-GTG GAG AAG AGC GAG AGC GG-3' and 5'-GGT GGA TGC TCT GTG CGT TG-3'. DNA probes were amplified by an initial cycle at 94°C for 3 min followed by 10 cycles of 94°C for 30 s, 58°C for 45 s and 72°C for 1 min, and ending with a 5 min extension at 72°C. PCR products were separated on 1% agarose gels.
Extracellular superoxide anion release : cytochrome c reduction
Ferricytochrome c reduction was measured as previously described (18). Briefly, cells were cultured in 6-well plates. When reaching confluence, they were treated with CoPP (20 µM), heme (1, 10 and 100 µM) or SnPP (20 µM) as described for western blot analysis. Twenty four hours after treatment, medium was removed, cells were washed twice with PBS. The medium was replaced with 1mg/ml ferricytochrome c in HBSS without phenol red. Each condition was made with and without 300 U/ml SOD. Cells were stimulated with 0.5 mg/ml opsonized zymosan for 15 minutes. The buffer was removed and absorbance at 550 nm was read immediately. Superoxide anion production was calculated from the differences in the absorbances between samples with and without SOD, using an extinction coefficient of 21. ). Heme content was expressed as pmol/ml.
Luminol-amplified chemiluminescence assay in rat alveolar macrophages
Male Sprague-Dawley rats (250 g) were purchased from Iffa Credo (France). They were treated with CoPP (15 mg/kg IP), or SnPP (30mg/kg IP) or vehicle. Forty eight hours after injection, they were anesthesied, the trachea was canulated with a 22G catheter through a tracheotomy. For bronchoalveolar lavage,15 ml cold sterile 0.9% sodium chloride was injected and re-aspired 5 times. BAL was centrifuged at 300 g for 5 minutes at 4°C. Then the supernatant was removed and the pellet was resuspended in 1ml HBSS. 
Statistical analysis
The values are given as the means ± S.E. The data were analyzed by one-way analysis of variance, the differences between the means were analyzed with the Fischer's protected least significant difference multiple comparison test or non-parametric analysis when appropriate.
The significance for all statistics was accepted at p<0.05.
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Results
Cellular toxicity and viability
No toxicity was observed with metalloporphyrins and heme at the doses used in the present study. Twenty-four hours after treatment with metalloporphyrins or heme, the percentage of 
HO-1 induction decreased cellular heme content
We first checked by western blot and confocal microscopy that incubation of RAW 264. HO-1 induction by CoPP induced a 30 % decrease in cellular heme content at 24 hours (Table   1) . On the opposite, HO inhibition by SnPP was followed by 385 % increase in heme and reversed CoPP-induced reduction in heme content.
HO-1 induction decreased NAD(P)H oxidase activity
Then, we examined the influence of HO-1 induction on NAD(P)H oxidase activity. In phagocytes, it is known that gp91 phox is non covalently associated with p22 
.
HO-1 induction in vivo inhibited NAD(P)H oxidase activity in alveolar macrophages from
CoPP-treated rats.
In order to verify the in vivo relevance of data obtained in cells, we evaluated gp91 phox protein expression and superoxide anion production in alveolar macrophages from rats treated with Heme oxygenase is the rate-limitating enzyme in heme breakdown and an important regulator of cellular heme availability. Heme degradation is critical for cell homeostasis, because of its potential pro-oxidant effects when it is in the free form (23) . Heme availability is also critical for activity of heme-dependent enzymes, like HO-1 itself which needs heme as its substrate (24) , or heme-containing enzymes. Expression and activity of cyclooxygenase-2 (25, 26) and nitric oxide synthase (27, 28) , two enzymes requiring heme in their catalytic site, are decreased after HO-1-induced heme depletion. Similarly, rats treated with CoPP exhibited a severe depletion in cellular cytochrome P450 (29) . We show in the present study that HO-1 can also modulate NAD(P)H oxidase activity through a similar mechanism. Indeed, HO-1 induction by CoPP in vitro in RAW 264.7 macrophages resulted in a decrease in both gp91 phox subunit protein expression and the whole NAD(P)H oxidase activity. These effects were associated in vitro with a decrease in heme content and were dose-dependently reversed by heme loading, suggesting that HO-1 controlled gp91 phox protein expression and activity via the control of the cellular heme pool. The lack of heme availability is probably not the only mechanism through which HO-1 can interact with NAD(P)H oxidase, as strongly suggested by the total inhibition of superoxide production by BAL macrophages, contrasting with a significant but much lower decrease in protein expression. We have previously demonstrated in airway smooth muscle that HO-1-released or exogenous added bilirubin could decrease superoxide anion production (12) (16).
This effect could be related to the oxidant scavenging properties of bilirubin (14) or to inhibition of NAD(P)H oxidase activation by this molecule (35) . Carbon monoxide, another HO product, has been also suggested to inhibit NAD(P)H oxidase activity because of its high affinity for heme moiety (36) . Thus, it appears that HO can inhibit NAD(P)H oxidase through different mechanisms.
In view of the present data, one can wonder whether NAD(P)H oxidase inhibition could take part to the antioxidant effect of HO and its beneficial consequences observed in different models of HO overexpression, especially in cardiovascular diseases. Indeed, NAD(P)H oxidase-generated superoxide anion takes part in control of expression of redox sensitivegenes and is strongly involved in atherosclerosis, hypertension and vascular remodeling (22, (38 -41) . Similarly, in humans, some authors have described a microsatellite polymorphism in the HO-1 promoter (small number of GT repeats in the promoter region responsible for a higher HO activity) associated with a reduced susceptibility to coronary disease (42) or restenosis after angioplasty (43) . In these studies, the antioxidant role of HO has been advocated to explain its protective effect, but an interaction with the oxidase function has never been postulated. Results from the present experiments in rats show that such a mechanism can be observed in vivo, since a single injection of CoPP strongly inhibits superoxide production. Further studies would be required to elucidate this point in pathological models.
Conclusion
This study provides evidences for an interaction between HO-1 activity and NAD(P)H oxidase expression, through regulation of cellular heme content. This interaction could explain antioxidant properties of the HO system and beneficial effects observed in different conditions such as cardiovascular diseases, in which involvement of the oxidase is well described. Moreover, given the wide distribution of the gp91 phox or its heme-containing homologs (NOX (9) Western blot and immunofluoresence were performed as described in the "Experimental procedures" section. Each experiment was repeated 3 times. Total RNA was extracted as described in "Experimental procedures" section, and analyzed by RT-PCR for gp91 phox , p22 phox , p47 phox and actin expression 
